美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
17772-131-60	17772-131	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	100 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-60)
17772-131-90	17772-131	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	100 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-90)
17772-132-01	17772-132	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	150 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-01)
17772-132-07	17772-132	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	150 mg/1	7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-07)
17772-132-30	17772-132	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	150 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-30)
17772-132-60	17772-132	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	150 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-60)
17772-132-90	17772-132	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	150 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-90)
17772-133-01	17772-133	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	200 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-01)
17772-133-07	17772-133	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	200 mg/1	7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-07)
17772-133-30	17772-133	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	200 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-30)
17772-133-60	17772-133	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	200 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-60)
17772-133-90	17772-133	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	200 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-90)
17772-131-30	17772-131	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	100 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-30)
17772-131-07	17772-131	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	100 mg/1	7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-07)
17772-131-01	17772-131	HUMAN PRESCRIPTION DRUG	QELBREE	viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402	N/A	NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	100 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01)